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Mononuclear cells are the first line of defense against microbial infection. Yet,
several viruses have evolved different mechanisms to overcome host defenses
to ensure their spread. Here, we show unique mechanisms of how equid
herpesvirus-1 manipulates peripheral blood mononuclear cells (PBMC) to travel
further in the body. (1) ‘‘PBMC-hitching’’: at the initial contact, herpesviruses
lurk in the extracellular matrix (ECM) of PBMC without entering the cells. The vi-
rus exploits the components of the ECM to bind, transport, and then egress to
infect other cells. (2) ‘‘Intracellular delivery’’: transendothelial migration is a phys-
iological mechanismwheremononuclear cells can transmigrate through the endo-
thelial cells. The virus was intangible and probably did not interfere with such a
mechanism where the infected PBMC can probably deliver the virus inside the
endothelium. (3) ‘‘Classical-fusion’’: this process is well mastered by herpesvi-
ruses due to a set of envelope glycoproteins that facilitate cell-cell fusion and
virus spread.
INTRODUCTION
Cell-to-cell transmission is one of the strategies adopted by several viruses to overcome host barriers and
to establish successful infection (Zhong et al., 2013). Several advantages have been documented for this
mode of transmission that center mainly on avoiding face-off engagement with host defenses (Gupta
et al., 1989; Mothes et al., 2010; Sattentau, 2008). Viruses have evolved several mechanisms, including
cell-cell fusion, synapse formation, and induction of actin tails, filopodial bridges, or nanotubes, and are
equipped with the necessary information to facilitate a secure and rapid cell-to-cell dissemination (Aubert
et al., 2009; Bennett et al., 2009; Sherer et al., 2007; Sowinski et al., 2008). Other modes of cell-to-cell trans-
mission involve the utilization of the carbohydrate-rich extracellular matrix (ECM) (Mothes et al., 2010). The
ability of viruses to utilize and hijack cell-cell contact machineries contributes to the success of viral infec-
tion and spreading.
The ECM is a complex three-dimensional structure present in all tissues that is generally composed of well-
organized networks of macromolecules (including polysaccharides and proteins) with distinct biochemical
and biomechanical properties (Stavolone and Lionetti, 2017). Moreover, besides providing a physical sup-
port for tissue integrity and elasticity, the ECM contributes functionally to the regulation of cell growth, sur-
vival, motility, intercellular adhesion and communication, as well as differentiation (Bonnans et al., 2014;
Stavolone and Lionetti, 2017). The ECM is a dynamic structure that is constantly remodeled and specifically
tuned in response to different physiological cell conditions as well as in response to diseases and infections
(Bonnans et al., 2014; Humphrey et al., 2014). Although ECM represents a formidable barrier against path-
ogen invasion, many viruses have evolved diverse mechanisms to overcome and even exploit the ECM for
entry and spread (Akhtar and Shukla, 2009; DiGiuseppe et al., 2017; Dimitrov, 2004). Human T cell leukemia
virus type 1 (HTLV-1) was shown to infect T lymphocytes and then bud into the ECM, which carries the virus
through virus-induced ECM components allowing virus spread and infection of other T lymphocytes (Pais-
Correia et al., 2010).
Infection of peripheral blood mononuclear cells (PBMC) plays a key role in disease outcomes because
PBMC have access to all body tissues. Although non-adherent, PBMC can adhere to endothelial cells
(EC) after stimulation, as is presumably the case after certain viral infections, where viruses can attach to,iScience 23, 101615, October 23, 2020 ª 2020 The Author(s).





Articleenter, and replicate in EC (Keller et al., 2003; Valbuena and Walker, 2006). The PBMC-EC interface thus
represents a crucial spot that can influence virus pathogenesis and disease outcomes. Infection of EC
through infected PBMC has been documented for members of several virus families, including bunya, her-
pes, filo, flavi, toga, and arena viruses (Charrel and de Lamballerie, 2010; Chu et al., 2016; Gowen and Hick-
erson, 2017; Kunz and de la Torre, 2017; Ma et al., 2013; Mackow and Gavrilovskaya, 2009). However, the
mechanism of how these viruses spread from infected PBMC to EC is only poorly understood. Disease out-
comes of these viral infections are mostly fatal (to humans and animals) due to hemorrhagic fevers, severe
respiratory diseases, as well as neurological and/or congenital disorders.
Herpesviruses represent a large group of DNA viruses that infect a wide variety of hosts. However, the
mechanism(s) used by herpesviruses to spread from cell to cell differs greatly depending on virus species
and their dedicated target cells or tissues. Cell-cell fusion, synapse formation, filopodial bridges, and nano-
tubes were documented for cytomegaloviruses (CMV), varicella zoster virus (VZV), pseudorabies virus (PRV),
and herpes simplex virus (HSV-1) (Cole and Grose, 2003; Dingwell et al., 1994; Favoreel et al., 2005; Gerna
et al., 2000; Sweet, 1999; van Leeuwen et al., 2002). Infection of PBMC with PRV, CMV, and VZV and subse-
quently their transfer to EC represents a critical step for viral pathogenesis. CMV and PRV were docu-
mented to spread between PBMC and EC via cell-cell (micro)fusion (Digel et al., 2006; Gerna et al.,
2000; Van de Walle et al., 2003). Equine herpesvirus type 1 (EHV-1) is another example of herpesviruses in-
fecting PBMC and then being transferred to EC via cell-associated viremia causing severe outcomes
including abortion, perinatal mortality, neurological disorders, and death (Chowdhury et al., 1986; Van
Maanen, 2002). Primary virus replication occurs in the respiratory epithelia of infected horses. The virus
rapidly reaches the lymphoid tissue associated with the upper respiratory tract, infects mononuclear cells
that enter bloodstream, and carry the virus within a short time frame to the vasculature of tissues, such as
the pregnant uterus or the central nervous system. The virus can spread and replicate in EC causing
different pathological injuries such as vasculitis, thrombosis, and ischemia (Smith et al., 1996; Wilson,
1997). However, the exact mechanism of virus spread is still unknown. EHV-4 infection, on the other
hand, is mainly restricted to the upper respiratory tract with very rare events of leukocyte-associated
viremia (Osterrieder and Van de Walle, 2010; Vandekerckhove et al., 2011). It is likely that this clear differ-
ence in EHV-1 and EHV-4 pathogenesis and disease outcomes is associated with differences in gene prod-
ucts, despite the significant genetic and antigenic similarity, that facilitate virus spread from cell to cell
(Sattentau, 2008). Using dynamic in vitromodels, we recently showed that EHV-1 was able to maintain teth-
ering and rolling of infected PBMC on EC, which resulted in virus transfer from PBMC to EC (Spiesschaert
et al., 2015a). Most remarkably, no EHV-1-productive infection in PBMC was observed, which, however,
does not exclude unambiguously restricted productive virus replication albeit at low levels (Drebert
et al., 2015; Laval et al., 2015; Spiesschaert et al., 2015a).
Here, we combine confocal imaging, live-cell imaging, and electron microscopy analyses together with
functional assays to study virus cell-to-cell spread between PBMC and EC. Our data unravels unique mech-
anisms of cell-to-cell transmission exploited by herpesviruses, in which the virus is embedded in the ECM of
PBMC without entering or infecting the cells. The embedded viruses were protected against circulating
neutralizing antibodies until the PBMC reached the EC, where the virus was released to infect the endothe-
lium. We were also able to document several transendothelial migration events of mononuclear cells
through EC, where infected PBMC might be able to deliver the virus directly inside the EC.RESULTS
Virus Embedding in the Carbohydrate-Rich Extracellular Matrix Structures
Confocal microscopy was performed to localize virus particles with respect to the plasma membrane and
the ECM of PBMC. We used an EHV-1 strain with a red fluorescent (mRFP) protein fused to the small capsid
protein VP26 (EHV-1RFP; to facilitate virus particle tracking) and the fluorescein isothiocyanate (FITC)-
labeled plant lectins (ConA andWGA) to stain glycan-rich carbohydrate components of the ECM. EHV-1RFP
(multiplicity of infection [MOI] = 0.5) was added to PBMC for different time periods (5 min, 1 h, 24 h, 2 days,
3 days, 5 days, and 7 days) at 37C, treated with ice-cold citrate buffer (pH 3) for 1.5 min to get rid of
ECM-unbound viruses, and then fixed with paraformaldehyde 4%.
Interestingly, we found that virus signals (either single viruses or clusters) were colocalizing with the ECM at
all time points, even after 7 days (5 min: Figures 1A and 1B; 1 and 24 h: Figures S1A and S1B; 1–7 days: Fig-
ure S2). The 3D image with virus particles colocalizing with the ECM after 5 min (Figure S1D) showed2 iScience 23, 101615, October 23, 2020
Figure 1. Colocalization of Virus Particles with the Carbohydrate-Rich Extracellular Matrix
(A–E) PBMCwere infected with EHV-1 RFP (red; MOI = 0.5) for 5 min. Cell surface glycoproteins of the ECMwere stained green
with FITC-labeled ConA (A), lectin from Triticum vulgaris (wheat germ agglutinin; WGA) (B), anti-collagen (C), anti-agrin (D), or
anti-ezrin (E). PBMCnucleuswas stainedwithDAPI (blue). Data are representatives of three independent experiments. Scale bar,
10 mm, and scale bar of magnification, 7 mm. Image stacks (number of stacks = 17 with 0.75 mm z stack step size) were





Articleembedding of EHV-1 viral particles in these structures. We only detected virus particles inside the infected
cells after 24 h of infection and up to 7 days (Figures S1C and S2).
To further confirm that virus particles were embedded in the ECM and not just bound to cell plasma mem-
brane, EHV-1RFP (MOI = 0.5) was added to PBMC for 5 min at 37C. The cells were stained with CellVue dye
to stain plasma membrane and FITC-labeled ConA to stain ECM. It was clear that virus particles were co-
localizing only with the ECM (Figure S3).iScience 23, 101615, October 23, 2020 3
Figure 2. Virus Transmission from Infected PBMC to EC under ‘‘Static’’ and ‘‘Dynamic’’ States
(A–F) Schematic depiction of contact (A), transwell (B), and flow chamber assays (C) is shown. PBMC were infected with EHV-1 GFP for different time periods
(5min, 1 h, and 6 h). Infected PBMC were overlaid on EC under ‘‘static’’ conditions (D) or allowed to flow over EC ‘‘dynamic’’ (E and F) in the presence of
neutralizing antibodies. Under dynamic conditions, whole PBMC population (E) and/or each PBMC subpopulation (T-lymphocyte, B-lymphocyte,
monocyte); (F) were infected for 5 min either at 37C (E and F) or at 4C (E). After 24 h, virus spread was assessed by counting the plaques on EC excluding the
inlet and outlet of the slide. As a control, infected PBMC or PBMC subpopulation were placed into a transwell insert without direct contact between EC and
PBMC ‘‘no contact.’’ The data represent the mean G standard deviation of three independent and blinded experiments. Significant differences in
plaque numbers were seen between different infection points under ‘‘static’’ conditions (*) (n = 3; one-way ANOVA test followed by multiple comparisons
tests; *p < 0.05; **p < 0.01). PBMC in (F) refers to whole PBMC population.
(G) Confocal microscopy of overlaid infected PBMC on endothelial cells after 2 h. ECM was stained green with FITC-labeled ConA (green), EHV-1 RFP viral
particles are red (arrowhead), and nucleus was stained with DAPI (blue). Data are representative of three independent experiments. Scale bar, 10 mm, and
scale bar of magnification, 7 mm. Image stacks (number of stacks = 17 with 0.75 mm z stack step size) were photographed using VisiScope Confocal FRAP
microscope. Presented here is a single optical section of the stacks.
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(H) Confocal live-cell imaging showing the transfer of EHV-1 RFP + GFP viral particles (red; arrowhead) from overlaid 5-min-infected PBMC to the endothelial
cells. Virus replication in EC is indicated by GFP expression (green), whereas RFP signals (at time points 03:44 and 05:36 min) represent new progeny RFP-
labeled virus production (red) in the infected cells. Image stacks (number of stacks = 15 with 0.5 mm z stack step size) were photographed using VisiScope
Confocal FRAP microscope. Presented here is a single optical section of the stacks.




ArticleComparison between infected (Figures 1A and 1B) and non-infected cells (Figures S4A and S4B) showed no
significant differences with respect to organization of the ECM glycans in infected and non-infected cells
(Figure S5).
We next looked at the components of the ECM and their colocalization with EHV-1RFP. Confocal micro-
scopy analyses were carried out after 5 min infection of PBMC with EHV-1RFP (MOI = 0.5). The cells were
stained for several surface proteins including collagen, agrin, and ezrin (Pais-Correia et al., 2010). We found
that virus particles were colocalized and clustered with collagen and agrin; however, there was no signifi-
cant reorganization of these proteins among infected and non-infected cells (Figures 1C, 1D, S4C, and
S4D). There was almost no colocalization of the virus particles with ezrin with no reorganization (Figures
1E and S4E). Heparinase enzyme treatment that hydrolyzes heparan sulfate (HS) proteoglycans resulted
in destruction of the ECM-bearing viral particles (Figure 4C) indicating their involvement as traps and/or
carriers of viruses.Spread of ECM-Associated Viruses from Infected PBMC to Endothelial Cells
To test virus transmission from infected PBMC to EC and the role of extracellular carbohydrate-rich matrix
structures, overlay assays (under either static or dynamic conditions) were performed. EHV-1GFP virus
(EHV-1 expresses the enhanced green fluorescent protein [EGFP] for rapid identification of infected cells)
was added to PBMC for different time periods (5min, 1 h, or 6 h) followed by citrate treatment asmentioned
above. Infected PBMC were then overlaid on EC in ‘‘contact’’ model (Figure 2A) for 2 h in the presence of
virus-neutralizing antibodies to prevent the infection of free virus particles, followed by extensive washing
several times to get rid of unbound PBMC. The ‘‘no-contact’’ model was used as a control to exclude cell-
free virus transmission (Figure 2B). Our data showed EHV-1 transmission from infected PBMC to EC at all
time points in the presence of neutralizing antibodies, including the early time point (5 min; Figure 2D). This
indicates that ECM-embedded viruses on the surface of PBMC were able to spread and replicate in the
target EC without previous entry into PBMC. In all cases, no virus transfer from infected PBMC to EC
was observed under ‘‘no-contact’’ conditions at all time points (Figure 2D).
As was shown in the stationary setup, we further expanded our investigation to test EHV-1 transfer under
dynamic conditions using a fluidic setup (flow chamber assay; Figure 2C). In this assay, EHV-1GFP was added
to PBMC for 5 min (at 37C or at 4C). At 4C, viruses are attached to the cells without entry or penetration.
Cells were allowed to flow over the confluent ECmonolayer in the presence of virus-neutralizing antibodies
to neutralize free virus particles. Our data showed that the 5-min-infected PBMC were able to transfer the
virus to EC under flow condition (Figure 2E). To determine which PBMC subpopulation might be respon-
sible for virus spread, PBMC were sorted and different subpopulations (T lymphocytes, B lymphocytes, or
monocytes) were infected with EHV-1 for 5 min and the cells were allowed to flow over EC in the presence of
virus-neutralizing antibodies. All PBMC subpopulations were able to transfer the virus to EC (Figure 2F). In
all cases, no virus transfer from infected PBMC or the subpopulations to EC was observed under ‘‘no-con-
tact’’ conditions (Figures 2E and 2F).
To further visualize virus transfer from PBMC to EC, EHV-1RFP was added to PBMC for 5 min, overlaid on EC
for 2 h, and analyzed using confocal microscopy. The z stack immunofluorescence confocal images came in-
line with the other infection assays showing PBMC in close proximity to EC with viral particles on the surface
of infected PBMC and the underneath EC (Figures 2G and S6).
To track EHV-1 transmission from the surface of infected PBMC to EC, time-lapse live cell imaging was per-
formed. After 5 min infection of PBMC with EHV-1RFP+GFP, the cells were added to EC and visualized by
time-lapse live cell imaging confocal microscopy. Interestingly, virus movement (represented by red
signals) from infected PBMC to EC was tracked at the early time points (within the first hour after adding
infected PBMC) and virus replication in EC (represented by GFP expression and production of progenyiScience 23, 101615, October 23, 2020 5
Figure 3. Virus Particles in the Interface between Infected-PBMC and EC
(A–F) (A) Fluorescence image of EC grown on gridded transmission electron microscope (TEM) coverslips and overlaid
with infected PBMC. PBMC were infected with EHV-1 RFP (MOI = 5) for 5 min and overlaid on EC. Red: mRFP-labeled
EHV-1; blue: Hoechst-stained nuclei. The insert shows one PBMC (red arrow) carrying a virus load and attached to one
endothelial cell. The dashed line indicates the direction of the targeted plane for ultrathin sectioning. TEM images of
targeted PBMC show virus particles (white arrows) on the surface of infected PBMC (B and C) as well as one virus particle
(white arrow) in the contact zone between infected PBMC and EC (D–F). Marked parts with rectangles in (B and E) are




ArticleRFP-labeled viruses) was visualized 2–3 h post overlay (Figures 2H and S7 and Video S1). No virus replica-
tion (no GFP expression) was detected in PBMC carrying the virus. The free red signals found in the field
might represent free virus particles or cell debris. It was clear that free virus particles, if present, were
not able to infect EC due to the presence of neutralizing antibodies in the medium. This conclusion was
confirmed by the absence of GFP-expressing EC (except the one with PBMC on top) and the transwell con-
trol assay (Figures 2D and 2E).
Taking all previous results together, the data display the role of extracellular carbohydrate-rich matrix in
virus PBMC-EC transmission that physically protects the virus against virus neutralizing antibodies and
possibly other immune reaction. This carbohydrate-rich ECM not only has a role in virus transmission be-
tween PBMC and EC but also probably has a role in viral transfer between PBMC themselves as the
PBMC tend to aggregate together in the infection than the non-infection state (Spiesschaert et al.,
2015a; van der Meulen et al., 2001) (Figure S8).Correlative Fluorescent and Electron Microscopy Identifies Virus Particles in the Interface
between PBMC and EC
Compared with fluorescence microscopy, transmission electron microscopy (TEM) provides a significantly
higher resolution, however, at the price of a much smaller field of view and elaborate sample preparation.
To further elucidate the mechanism of virus transfer between PBMC and EC at ultrastructural level, we
applied a correlative workflow to identify and target individual virus-loaded PBMC in close proximity to
EC. EC were grown on gridded coverslips, incubated with EHV-1RFP-infected PBMC, and imaged using
an automated wide-field fluorescence microscope (CellDiscoverer7, Zeiss). To unambiguously identify
PBMC comprising a more compact, nearly spherical nuclei compared with EC, Hoechst was used to coun-
terstain the nucleus. PBMC showing a discrete, punctual RFP signal (indicating individual virus particles)
located in close proximity to EC were targeted during TEM sample preparation and ultrathin sectioning6 iScience 23, 101615, October 23, 2020
Figure 4. Relevance of Extracellular Carbohydrate-Rich Matrix in EHV-1 Cell-to-Cell Spread
(A and B) PBMC were infected with EHV-1 RFP + GFP (MOI = 0.1) for 5 min. The ECM were disrupted mechanically
(extensive pipetting; EHV-1_5M_Cell_pip), chemically (heparin treatment; EHV-1_5M_Cell_hep), or both
(EHV-1_5M_Cell_pip_hep). The disrupted cells (A) or the supernatant (EHV-1_5M_Sup_pip, EHV-1_5M_Sup_hep,
EHV-1_5M_Sup_pip_hep) (B) were added to EC. As a control, the ECM was left undisrupted (EHV-1_5M_Cell
or EHV-1_5M_Sup). The data represent the mean G standard deviation of three independent and blinded experiments.
Significant differences in plaque numbers on EC were seen between the different treatment procedures. n = 3; one-way
ANOVA test and Dunnett’s multiple comparisons test; **p < 0.01, ***p < 0.001.
(C and D) Treatment with heparinase III or heparin fractionates and elution of ECM-viral assemblies. Confocal microscopy
showing infected PBMC with EHV-1 RFP + GFP (red) treated with heparinase III (C) or heparin (D) and stained for cell
surface carbohydrate-rich matrix with ConA (green). PBMC nucleus was stained with DAPI (blue). Data are representative
of three independent experiments. Scale bar, 10 mm, and scale bar of magnification, 7 mm. Image stacks (number of
stacks = 17 with 0.75 mm z stack step size) were photographed using VisiScope Confocal FRAP microscope. Presented




Articlebased on their position relative to the coverslip grid (Figure 3A). We observed the presence of enveloped
EHV-1 particles on the surface of infected PBMC that are approaching the resting EC (Figures 3B, 3C, and
S9). Interestingly, virus particles were found in the intercellular space between tightly interacting infected
PBMC and EC (Figures 3D–3F). We did not find evidence of virus budding from the PBMC or fusion events
between infected PBMC and EC plasma membranes at this time point (5 min infection of PBMC and 1 h
overlaying incubation period, see Transparent Methods). This further indicates that virus particles might
be transported embedded on the surface of PBMC and do not necessarily need to enter them.
Destruction of ECM-Associated Virus Clusters Reduces Virus Spread
To unravel the prominence of the extracellular carbohydrate-rich matrix in virus transmission from PBMC to
EC, extracellular viral clusters were disrupted mechanically by vigorous pipetting, chemically by heparin or
heparinase treatment, or both (pipetting and heparin treatment). Heparin has been shown to compete with
HS for binding to protein components of the ECM leading to its removal from the cell surface (Pais-Correia
et al., 2010; Tarasevich et al., 2015). Heparinase enzyme has been shown to cleave HS proteoglycans




Articleand added to EC monolayers. Treatment with heparinase III or heparin leads to the detachment of ECM-
viral assemblies (Figures 4C and 4D). Partial destruction of the ECM clearly leads to a significant reduction
in virus transfer between PBMC and EC accompanied by reduction of EC infection rates (Figure 4A). On the
other hand, supernatants from treated PBMC contained more ECM-viral assemblies and gained a signifi-
cant increase in infectivity after adding to EC, even in the presence of virus-neutralizing antibodies (Fig-
ure 4B). Although PBMC treatment significantly reduced virus spread, it did not completely abolish virus
transmission due to the remaining ECM-virus clusters on the surface of PBMC that can still transfer the virus
(Figures 4C and 4D). These results indicate that integrity of ECM is essential in virus transmission from
PBMC to EC.
Transendothelial Migration of PBMC through the Endothelial Cell
Mononuclear cell migration across the endothelial barrier is a distinct process that can be through either
the endothelial junctions (paracellular) or the EC body (transcellular) (Muller, 2013; Schimmel et al., 2017).
The process of transendothelial migration is usually preceded by orchestrated steps starting with rolling,
firm adhesion, and microvillar projections invaginating the endothelium that might trigger transmigration
(Schmidt et al., 2011). While running TEM analysis, we noticed several PBMC behaving as they are prepar-
ing for transmigration; they firmly attached to EC and having projections into the EC (Figures 5A and 5B).
We further detected intact PBMC transmigrating through the EC (Figures 5C–5F). Interestingly, we could
identify in several occasions incorporated infected PBMC (with virus particles) inside EC; however, they
seem to be partially digested (Figures 5G–5L and S10). We further detected virus particle on the surface
of a digested PBMC within EC (Figures 5G–5I). This pathway might represent a novel strategy and a mech-
anism of direct intracellular cell-to-cell spread of viruses.
Cell-to-Cell Fusion Events between Infected PBMC and EC
To test the possible incidence of classical fusion events between infected PBMC and EC, PBMC were trans-
fected with mRFP-expressing plasmid and infected with EHV-1GFP for 24 h to allow virus replication and
expression of virus fusion machinery (namely, gD, gB, gH-gL) on the surface of infected PBMC (Figure S11).
PBMC were then co-cultured with the target EC for 3 h. Upon adhesion, infected PBMC fused with the un-
derlying uninfected EC, which leads to the transfer of their red cytoplasm as well as intracellular virions be-
tween the two cells. EC expressed GFP due to virus replication after transfer through the fusion canal
(Figure 6A).
In another assay, PBMCwere transfectedwith T7 RNApolymerase-encoding plasmid and then infectedwith
EHV-1GFP (Trans_inf_PBMC). PBMC were overlaid on EC transfected with a plasmid encoding luciferase
gene under a T7 promoter (Trans_EC). As negative controls, PBMC were either transfected with the T7
RNA polymerase-encoding plasmid without infection or infected with EHV-1GFP without transfection. In
all cases, the EC were transfected with a plasmid encoding luciferase under a T7 promoter. As a positive
control, PBMC were transfected with the two plasmids encoding T7 RNA polymerase and luciferase under
a T7 promoter. Luciferase activity was recorded as a measure of cell-cell fusion. PBMC-EC fusion events
were only detected in the setup where PBMCwere first transfected and infected and then overlaid on trans-
fected EC. Transfection of PBMC with both plasmids gave the same luciferase activity (Figure 6B).
No Transmission Events for ECM-Clustered EHV-4
We have shown before that EHV-4 was unable to spread (under contact or dynamic conditions) from in-
fected PBMC to EC (Spiesschaert et al., 2015a). Here, we show that EHV-4, like EHV-1, was clustered
with the extracellular carbohydrate-rich matrix of infected PBMC (Figure S12A). However, infected
PBMC were not able to transfer EHV-4GFP to EC as shown in the contact assay (Figure S12B) and the
flow chamber assay (Figure S12C). Destruction of the extracellular carbohydrate-rich structures from in-
fected PBMC by extensive pipetting and heparin treatment released ECM-virus assemblies into the me-
dium; however, these assemblies were not infectious to EC as shown for EHV-1 (Figure S12D). It is worth
mentioning that EC preparations are permissive for EHV-4 infection using free infectious virus produced
by equine dermal (ED) cells (Figure S12E).
Viral gB and gD Influence ECM-Associated Virus Cell-to-Cell Transmission
From our results, it was clear that both EHV-1 and EHV-4 are embedded in the ECM of infected PBMC
before entering the cell itself. However, only EHV-1 was able to step forward and spread to infect EC at8 iScience 23, 101615, October 23, 2020
Figure 5. Transcellular Migration of Infected-PBMC through Endothelial Cells
(A–L) Ultrathin cross sections of PBMC adherent to and crossing endothelial cells. PBMCwere infected for 5 min with EHV-
1 RFP and incubated over adherent EC for 3 h. Multiple intracellular protrusions invaginating the apical endothelial
membrane (A and B; black arrows) and PBMCmigrating through the endothelial cells (C) are shown. Intact PBMC is shown
within the cytoplasm of EC (D–F; red arrow). Migrating PBMC (E) is marked with a rectangle and further magnified (F, red
arrow). Partially digested infected PBMC is shown (G–L) and marked with a rectangle, which is magnified (H–I and K–L).
Virus particles attached to migrating PBMC (either outside, H and I, or inside, K and L) are marked with white arrows. Scale
bar, 1 mm. See also Figures S10 and S13.
ll
OPEN ACCESS
iScience 23, 101615, October 23, 2020 9
iScience
Article
Figure 6. Cell-Cell Membrane Fusion Induced by EHV-1
(A) Fusion between PBMC and ECwas visualized using confocal laser scanningmicroscope. Expression of mRFP protein is
indicated by red and EHV-1 GFP replication is represented by green after GFP expression, which is integrated in the viral
genome. Colocalization of both colors is shown in the merge panel. Data are representative of two independent
experiments. Scale bar, 10 mm, and scale bar of magnification, 7 mm. Image stacks (number of stacks = 17 with 0.75 mm z
stack step size) were photographed using VisiScope Confocal FRAPmicroscope. Presented here is a single optical section
of the stacks.
(B) Fusion between infected PBMC and EC was further detected by luciferase activity. Results are shown as means of three
independent and blinded experiments with standard errors and are presented as luciferase luminescence unit (RLU). The
asterisk indicates p value <0.05 using Kruskal-Wallis test followed by Dunns test for multiple comparisons. Infected PBMC
only (Inf_PBMC + Trans_EC) and transfected PBMC only (Trans_PBMC + Trans_EC) were used as negative controls.
Control positive is represented by transfected PBMC with both plasmids (double Trans_PBMC). Trans_inf_PBMC +
Trans_EC:PBMCwas transfected with T7 RNA polymerase-encoding plasmid, then infected with EHV-1 GFP, and overlaid




Articleearly time point. Several factors can be involved in this privilege of EHV-1; of interest are the envelope gly-
coproteins involved in virus entry (Azab and Osterrieder, 2017b). The role of two envelope proteins gB and
gD in virus transmission was tested. The two genes were swapped between EHV-1 and EHV-4 (Azab and
Osterrieder, 2012; Spiesschaert et al., 2015b), PBMC were infected for 5 min with either EHV-1_gB4
and EHV-1_gD4 or EHV-4_gB1 and EHV-4_gD1, and infected PBMC were added to EC in ‘‘contact’’ and
‘‘flow chamber’’ models. Interestingly, swapping the two genes significantly affected ECM-associated virus
spread from infected PBMC to EC. The recombinant viruses (EHV-4_gB1 and gD1) were able to spread and
infect EC under ‘‘contact’’ condition only (Figures 7B and 7D). On the other hand, EHV-1_gD4
and EHV-1_gB4 showed a significant reduction in virus transfer when compared with parental EHV-1, under
both static and dynamic conditions (Figures 7A and 7C).DISCUSSION
As successful parasites, viruses have evolved several and diverse mechanisms to facilitate rapid cell-to-cell
dissemination and to promote immune evasion (Mothes et al., 2010; Sattentau, 2008). Different pathways of
cell-to-cell spread have been identified that fall mainly into two main categories; (1) cell-free viruses: where
intracellular viruses are released into the extracellular space and infected new cells; (2) direct cell-to-cell
contact: where intracellular viruses spread from one cell to another without being extracellularly egressed
(Marsh and Helenius, 2006; Mothes et al., 2010; Sattentau, 2011). Here, we document two unique pathways
of virus transmission that include (1) the embedding of virus particles in the ECM without entering the cells
and (2) a possible intracellular delivery during transendothelial migration of infected PBMC into EC. The
ECM-associated viruses are protected from the immune attack and efficiently spread from infected10 iScience 23, 101615, October 23, 2020
Figure 7. Role of Viral gB and gD in Virus Transmission
(A–D) PBMC were infected with the indicated viruses (MOI = 0.1) for 5 min. Infected PBMC were overlaid on EC under
‘‘static’’ conditions (A and B) or allowed to flow over EC ‘‘dynamic’’ (C and D) in the presence of neutralizing antibodies.
After 24 h, virus spread was assessed by counting the plaques on EC. As a control, infected PBMC were placed into a
transwell insert without direct contact between EC and PBMC ‘‘no contact.’’ The data represent the mean G standard
deviation of three independent and blinded experiments. Significant differences in plaque numbers were seen between
the different viruses as indicated. One-way ANOVA test followed by Dunnett’s multiple comparisons test (B) or Kruskal-




ArticlePBMC to other immune cells or to EC. Furthermore, infected PBMC can transmigrate through the EC where
ECM-associated viruses can be delivered directly inside EC.
The portal of entry is not the ultimate goal of herpesviruses, and they need to travel (through either blood
or nerve) to their preferred tissues where they can establish latency or induce disease (Adler et al., 2017). To
achieve this goal, different mechanisms of direct cell-to-cell spread have been documented including cell-
cell fusion, synapse formation, or tunneling nanotubes (Gerna et al., 2000; Jansens et al., 2017; Saksena
et al., 2006). The pathogenesis of EHV-1 is distinct from other members of the Herpesviridae family. Infec-
tion starts first at the respiratory epithelium where PBMC contracts the virus and delivers it to the endothe-
lium (Ma et al., 2013; Smith et al., 2001). Infection of PBMC and subsequent virus spread to the endothelium
are still to be understood. We and others have shown that virus replication in PBMC is ‘‘restricted’’ without
obvious viral protein production or expression on the cell surface. However, when infected PBMC reach the
endothelium, the virus finds its way outside the PBMC to infect new cells, probably through cell-cell fusion
(Laval et al., 2015; Spiesschaert et al., 2015a). This pathway provides a secure trip for the virus without being
attacked by the immune system. In the mechanism that we provide here for the first time, PBMC (during the
first hour of infection) carry the virus on its surface associated with the ECM; the virus does not enter the
cells. Although appeared to be exposed to the surrounding environment, viruses are fully protected
against neutralizing antibodies that prevented free virus spread. Upon contact with EC either under ‘‘static’’




Articlesubpopulations of PBMC (T lymphocytes, B lymphocytes, and monocytes) could transfer the virus to EC
early after infection. It would be interesting, for future studies, to stain ECM on the surface of each subpop-
ulation to determine virus localization on the surface of these cells.
We next asked the question whether this mechanism is spontaneous and any virus can be stuck to the sur-
face of PBMC and then spread. EHV-4, a close relative to EHV-1 and having a restricted pathogenesis to the
upper respiratory tract, was not able to spread to the endothelium, although it was also stuck to the ECM.
This indicates that EHV-1 exploits the existing natural ECM and hides in this complex network until it rea-
ches the endothelium where it can exit the surrounding matrix and infect EC. ECM-associated viruses can
also be spread to other non-infected PBMC in the circulation or in secondary lymphoid organs. It was
shown that dendritic cells contract EHV-1 infection from the respiratory epithelium (Vandekerckhove
et al., 2011); in turn, other cells may get infected after contacting EHV-1 clusters on the surface of dendritic
cells. A similar but distinct mechanism was described before for HTLV-1 virus (Pais-Correia et al., 2010). It
has been shown that HTLV-1-infected lymphocytes produce and store viral particles as extracellular assem-
blies attached to cell surface extracellular components through a virus-induced mechanism. HTLV-1 seems
to hijack certain host cell proteins and enhance their expression to build the extracellular assemblies. In
that case, virus infection takes place first within the cells where the virus can modify the carbohydrate com-
positions and/or their spatial organization. The virus then buds into and accumulates in the extracellular
structures that may locally increase the infectious titer and facilitate HTLV-1 cell-to-cell spread (Pais-Correia
et al., 2010).
In the natural situation where horses are infected with EHV-1, PBMC transfer the virus from the site of pri-
mary infection in respiratory epithelia to the endothelium. In this pathway, PBMCmight take hours to reach
lymph nodes and days until viremia develops. We show here that PBMC can keep the virus on its surface
(associated with the ECM) for up to 7 days, which may point to their ability to transfer the extracellular vi-
ruses to EC. However, transfer of intracellular virus particles through cell-cell fusion or any other mechanism
cannot be excluded.
Interestingly, we detected enveloped EHV-1 in the interface between tightly interacting infected PBMC
and EC. Our correlative approach enables us to roughly target infected PBMC in close proximity to EC dur-
ing TEM sample preparation, whereas visualizing virus particles with180 nm diameter within 50- to 70-nm
ultrathin section through an entire cell is still a rare event and thus remains challenging. Fluorescence
signals from single labeled virus particles are weak, and most fluorophores are not compatible with
resin-embedding procedures. Using fluorescence imaging is thus difficult to target rare events on ultrathin
sections before TEM imaging. Further investigating the mechanism of virus transfer at the ultrastructural
level would need serial sectioning techniques such as SEM array tomography or block face imaging to
reconstruct large volumes, hence increasing the probability to capture rare events within their cellular
context.
The composition of ECM is diverse but falls into two classes of macromolecules, namely, proteoglycans
and fibrous proteins (Järveläinen et al., 2009; Schaefer and Schaefer, 2010; Stavolone and Lionetti, 2017).
Glycosaminoglycan (GAG) chains composed of HS and chondroitin sulfate fill the majority of the ECM
(Stavolone and Lionetti, 2017). Several viruses, including herpesviruses, have been shown to interact
with HS in a charge-based and a relatively non-specific manner (Azab and Osterrieder, 2017a; Barth
et al., 2003; Chen et al., 1997; Tyagi et al., 2001). Herpesvirus envelope glycoproteins (gC and gB) interact
reversibly with HS, which lead to virus concentration at the cell surface (Azab and Osterrieder, 2017a) and
can explain the embedding of EHV-1 within the ECM. We further showed that virus particles are coloc-
alizing with agrin and collagen of the ECM. The HS proteoglycan, agrin, plays a key role in efficient cell-
to-cell communication at the synaptic zone (Alfsen et al., 2005; Dustin and Dustin, 2001; Khan et al., 2001)
and in virus cell-to-cell transmission (Alfsen et al., 2005; Dityatev and Schachner, 2006; Pais-Correia et al.,
2010). It is worthy to mention that the role of synapse formation in EHV-1 spread has not yet been eluci-
dated. Collagens are the most abundant structural element of the ECM and play a role in the regulation
of cell adhesion, providing tensile strength and supporting chemotaxis and migration (Rozario and De-
Simone, 2010). The actual interaction of the virus with the two proteins and their exact role in virus trans-
mission need to be elucidated. We barely detected a colocalization with ezrin protein, which is a member
of the ECM protein family and plays a key role in cell surface structure adhesion, migration, and organi-




ArticleThe chemical compositions (GAGs and fibrous proteins) of ECMendowed thismatrix with its gelatinous proper-
ties that play important physiological roles (Rhodes and Simons, 2007). To investigate the functional relevance of
ECM integrity on virus spread, we applied mechanical and/or chemical (through heparin or heparinase enzyme)
shearing forces to the infected cells. Partial destruction of EHV-1-associated ECM, although did not completely
remove virus-ECM structures, significantly reduced virus cell-to-cell spread and the overall infectious capacity of
PBMC. Cell supernatants obtained after ECM destruction, on the other hand, contained more virus assemblies
and gained more infectivity even in the presence of neutralizing antibodies. Interestingly, destruction of
EHV-4-associatedECMdidnot result in any infectivity at both levels (cell-to-cell or supernatants). Taken together,
this indicates that the integrityofECMisessential forEHV-1 transfer at thePBMC-EC interface. Further studieswill
beneededtounravel thecomposition, structure, regulation,and functionof theECMofPBMC.EHV-1wasable to
egress the ECMat certain timepoint, probablywhen reaching the EC, through a virus-specificmechanism, which
is not available for its close relative (EHV-4).
EHV-1 interaction with the ECM components of PBMC and its subsequent egress when reaching the EC is
enigmatic. Several herpesvirus glycoproteins have been implicated in cell-to-cell spread (Azab and Oster-
rieder, 2017a). Two candidates (gB and gD) have been shown to have essential roles in virus entry, pene-
tration, and tissue tropism. In all members of Herpesviridae family, gB is a highly conserved fusogenic
protein and it interacts with HS or other specific cell receptors. gD, when present, is the main receptor-
binding protein that triggers the entry steps (Azab and Osterrieder, 2017a). Swapping gB and gD between
EHV-1 and EHV-4 resulted in a dramatic change in virus infectious ability. ECM-associated EHV-1 with
either gD4 or gB4 showed a significant reduction in cell-to-cell spread. On the other hand, EHV-4 with
gB1 or gD1 obtained, for the first time, the ability to spread from infected PBMC to EC. We surmise that
EHV-1 gD and gB were able to interact with certain structures of the ECM, such as HS or yet unidentified
cell receptors, that keep the virus attached during the whole trip. How the virus breaks this interaction to
infect the EC is unknown. It is possible that the virus interacts with EC while attaching to the ECM of PBMC.
Another explanation could be that the virus adheres avidly to the ECM deposited by EC before penetra-
tion. It is possible that following virus binding to the ECM of PBMC, the ECM could be remodeled resulting
in the virus having greater affinity for the ECM of EC. Such interaction with EC can be stronger and specific
to influence virus transfer from a temporary situation on the surface of PBMC to a stable one on EC. The
clear difference between the fusogenic functions of EHV-1 and EHV-4 gBs can also explain the difference
of infection outcomes (Spiesschaert et al., 2015b). The interaction of EHV-1 gD with new cell receptors on
the surface of EC cannot be excluded. Detection of EHV4 associated with the ECM indicates that the virus
can interact or, at least, be captured by the gelatinous nature of the ECM. However, the failure of virus
egress to infect EC can be interpreted by the absence of suitable genetic makeup that can support its
release. Being stuck longer may lead to its inactivation on the surface of PBMC as a defense mechanism
as previously shown with Newcastle disease virus (Yaacov et al., 2012). This interpretation is supported
by the ability of EHV-4 to egress and infect EC after supporting its genome with more powerful genes
(gD and gB) from EHV-1.
Transcellular and paracellular pathways have been described to illustrate PBMC migration through the
endothelial barrier (Engelhardt and Wolburg, 2004; Muller, 2011). Although the process of transcellular
migration and the influencing factors are not fully understood, the entire process of trafficking through
the endothelium requires three basic steps: rolling, adhesion, and transmigration (Schmidt et al., 2011).
We have recently shown that EHV-1-infected PBMC have the ability to roll and then adhere to the endothe-
lium to facilitate virus spread, probably after the upregulation of certain adhesion molecules and cytokines
(Holz et al., 2017; Proft et al., 2016; Spiesschaert et al., 2015a). Here, we document the final step of traf-
ficking and show that infected PBMC can migrate through the endothelium in a process that might lead
to a safe delivery of the virus inside the cell. Although such a mechanism may not represent the default
pathway of virus transmission, the possibility to be an ‘‘alternative’’ pathway cannot be excluded. Transmi-
gration of peripheral mononuclear cells containing bacteria through epithelial cells was previously re-
ported (Wewer et al., 2011). It was shown that infection with Streptococcus suis enhanced the process of
transcellular migration. Whether EHV-1 has an influencing effect remains to be investigated. We noticed
that the transmigrating infected PBMC was digested within a cytoplasmic vacuole. It seems that lysis of
naive PBMC during transmigration is an expected process (Figure S13) (Bedoya et al., 1969; Herman
et al., 2019). However, it is also possible that virus particles on the surface of PBMC may trigger cell lysis.
As transendothelial migration is a rare event and cannot be easily captured by TEM, we could not detect




Articledigested PBMC. We surmise that virus particles are able to escape from the vacuole before complete lysis
through fusion with the vacuole membrane; a process that is well mastered by herpesviruses (Atanasiu
et al., 2010).
Cell-cell fusion is considered the classical and most investigated event of herpesvirus transmission (Cole
and Grose, 2003). EHV-1-infected PBMC were capable of transferring infected cytoplasmic material into
uninfected EC through fusion events. These results are described before for other herpesviruses including
HCMV, PRV, and a VZV (Digel et al., 2006; Gerna et al., 2000; Van de Walle et al., 2003) as well as other vi-
ruses (Duprex et al., 1999; Takeuchi et al., 2003). In general, herpesviruses are equipped with a set of gly-
coproteins (gD, gB, gH, and gL) that carry out all fusion events either between the virus and cells or between
infected and non-infected cells (Ambrosini and Enquist, 2015; Atanasiu et al., 2010). During viremia, in-
fected PBMC slow down, roll over the endothelium, and finally adhere to EC. Such a process gives the in-
fected cells a chance to establish cell-cell fusion due to replication of intracellular virus particles and
expression of viral envelope glycoproteins on the surface of infected PBMC. Interestingly, all detected
fusion events were in PBMC infected for 24 h, where viruses already entered the cells and produced the
needed glycoproteins for fusion (Van de Walle et al., 2003).
In conclusion, among all viruses, herpesviruses have proven themselves as ‘‘masters of co-evolution.’’ It is
surprising how herpesviruses manipulate infected PBMC with different mechanisms and pathways to
ensure a safe and secure spread in the same scene. (1) ‘‘PBMC-hitching’’: at the first hit, herpesviruses atta-
ch to the ECM, hide, transport, and then egress to infect other cells. (2) ‘‘Intracellular delivery’’: transendo-
thelial migration of infected PBMC may lead to a direct delivery of the virus inside the cytoplasm of EC. (3)
‘‘Classical-fusion’’: this event is well controlled by herpesviruses and always occurs to facilitate virus spread.Limitations of the Study
Animal study is the main limitation of this study. It is difficult to determine virus spread from PBMC to EC
in vivo. One possible animal study could be the infection of horses with EHV-1RFP and collecting PBMC at
different time points during viremia and check whether the virus could be present on the surface of the
cells. However, this will not prove that the virus was stuck from the beginning on the surface of PBMC.
Another limitation is the confirmation that viruses delivered intracellularly with migrating PBMC are infec-
tious. To conduct such experiment, we will need to isolate EC with infected PBMC inside and propagate
them separately to track if they will develop infection; however, this is technically very difficult. Finally, char-
acterization of the ECM of PBMC and determining their composition, structure, regulation, and function
would add significantly to our understanding of virus spread. However, conducting this experiment was
severely affected by the current COVID-19 pandemic, which hindered our regular access to the
laboratories.Resource Availability
Lead Contact
Further information and requests for resources and reagents or data should be directed to and will be ful-
filled by the Lead Contact, Walid Azab: walid.azab@fu-berlin.de.
Materials Availability
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All methods can be found in the accompanying Transparent Methods supplemental file.SUPPLEMENTAL INFORMATION





This work was supported by a grant from Deutsche Forschungsgemeinschaft (AZ 97/3-2) to W.A.. M.K. was
supported by a scholarship from the Egyptian Ministry of Higher Education (MoHE) and the German Aca-
demic Exchange Service (DAAD). We thank Prof. Dr. Klaus Osterrieder for the useful discussion. We thank
Prof. Dr. Heidrun Gehlen, Horse Clinic, Freie Universitaet Berlin, for providing horse blood for PBMC isola-
tion. We thank Prof. Dr. Johanna Plendl, Institut für Veterinär-Anatomie, Freie Universitaet Berlin for
providing endothelial cells. We thank Oleksandr Kolyvushko for helping with the live cell imaging and Mi-
chaela Zeitlow for technical assistance.
AUTHOR CONTRIBUTIONS
First author M.K. designed and conducted most of the experiments, designed the figures, and wrote the
manuscript. Coauthor S.P. designed and conducted the live cell imaging and prepared the samples for
EM, designed live cell imaging figures and movie, and wrote part of the manuscript. Coauthor B.F. de-
signed and conducted the EM experiment. Coauthor T.M. designed and conducted the EM experiment,
conducted data analysis of the EM pictures, and wrote part of the manuscript. Corresponding author
W.A. designed the project, discussed the results at different stages of work, and wrote and corrected
the manuscript.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: April 23, 2020
Revised: August 27, 2020
Accepted: September 23, 2020
Published: October 23, 2020REFERENCES
Adler, B., Sattler, C., and Adler, H. (2017).
Herpesviruses and their host cells: a successful
liaison. Trends Microbiol. 25, 229–241.
Akhtar, J., and Shukla, D. (2009). Viral entry
mechanisms: cellular and viral mediators of
herpes simplex virus entry. FEBS J. 276, 7228–
7236.
Alfsen, A., Yu, H., Magérus-Chatinet, A., Schmitt,
A., and Bomsel, M. (2005). HIV-1-infected blood
mononuclear cells form an integrin-and agrin-
dependent viral synapse to induce efficient HIV-1
transcytosis across epithelial cell monolayer. Mol.
Biol. Cell 16, 4267–4279.
Ambrosini, A.E., and Enquist, L.W. (2015). Cell-
fusion events induced by a-herpesviruses. Future
Virol. 10, 185–200.
Atanasiu, D., Saw, W.T., Cohen, G.H., and
Eisenberg, R.J. (2010). Cascade of events
governing cell-cell fusion induced by herpes
simplex virus glycoproteins gD, gH/gL, and gB.
J. Virol. 84, 12292–12299.
Aubert, M., Yoon, M., Sloan, D.D., Spear, P.G.,
and Jerome, K.R. (2009). The virological synapse
facilitates herpes simplex virus entry into T cells.
J. Virol. 83, 6171–6183.
Azab, W., and Osterrieder, K. (2017a). Initial
contact: the first steps in herpesvirus entry. Adv.
Anat. Embryol. Cell Biol. 223, 1–27.
Azab, W., and Osterrieder, K. (2017b). Initial
contact: the first steps in herpesvirus entry. In Cell
Biology of Herpes Viruses (Springer), pp. 1–27.Azab, W., and Osterrieder, N. (2012).
Glycoproteins D of equine herpesvirus type 1
(EHV-1) and EHV-4 determine cellular tropism
independently of integrins. J. Virol. 86, 2031–
2044.
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Jääskeläinen, J., Majander-Nordenswan, P.,
Sainio, M., Timonen, T., and Turunen, O. (1997).
The ezrin protein family: membrane-cytoskeletoninteractions and disease associations. Curr. Opin.
Cell Biol. 9, 659–666.
Valbuena, G., and Walker, D.H. (2006). The
endothelium as a target for infections. Annu. Rev.
Pathol. Mech. 1, 171–198.
Van de Walle, G.R., Favoreel, H.W., Nauwynck,
H.J., Mettenleiter, T.C., and Pensaert,M.B. (2003).
Transmission of pseudorabies virus from
immune-masked bloodmonocytes to endothelial
cells. J. Gen. Virol. 84, 629–637.
van der Meulen, K.M., Nauwynck, H.J., and
Pensaert, M.B. (2001). Mitogen stimulation
favours replication of equine herpesvirus-1 in
equine blood mononuclear cells by inducing cell
proliferation and formation of close intercellular
contacts. J. Gen. Virol. 82, 1951–1957.
van Leeuwen, H., Elliott, G., andO’Hare, P. (2002).
Evidence of a role for nonmuscle myosin II in
herpes simplex virus type 1 egress. J. Virol. 76,
3471–3481.
Van Maanen, C. (2002). Equine herpesvirus 1 and
4 infections: an update. Vet. Q. 24, 57–78.
Vandekerckhove, A.P., Glorieux, S., Gryspeerdt,
A., Steukers, L., Van Doorsselaere, J., Osterrieder,N., Van de Walle, G., and Nauwynck, H. (2011).
Equine alphaherpesviruses (EHV-1 and EHV-4)
differ in their efficiency to infect mononuclear
cells during early steps of infection in nasal
mucosal explants. Vet. Microbiol. 152, 21–28.
Wewer, C., Seibt, A., Wolburg, H., Greune, L.,
Schmidt, M.A., Berger, J., Galla, H.J., Quitsch, U.,
Schwerk, C., Schroten, H., et al. (2011).
Transcellular migration of neutrophil
granulocytes through the blood-cerebrospinal
fluid barrier after infection with Streptococcus
suis. J. Neuroinflamm. 8, 51.
Wilson, W.D. (1997). Equine herpesvirus 1
myeloencephalopathy. Vet. Clin. North Am.
Equine Pract. 13, 53–72.
Yaacov, B., Lazar, I., Tayeb, S., Frank, S., Izhar, U.,
Lotem, M., Perlman, R., Ben-Yehuda, D., Zakay-
Rones, Z., and Panet, A. (2012). Extracellular
matrix constituents interfere with Newcastle
disease virus spread in solid tissue and diminish
its potential oncolytic activity. J. Gen. Virol. 93,
1664–1672.
Zhong, P., Agosto, L.M., Munro, J.B., andMothes,
W. (2013). Cell-to-cell transmission of viruses.
Curr. Opin. Virol. 3, 44–50.iScience 23, 101615, October 23, 2020 17
iScience, Volume 23Supplemental InformationEquid Herpesvirus-1 Exploits
the Extracellular Matrix of Mononuclear Cells
to Ensure Transport to Target Cells
Mohamed Kamel, Selvaraj Pavulraj, Beatrix Fauler, Thorsten Mielke, and Walid Azab
 
Supplemental Information 1 
 2 
Supplemental figures and legends 3 
  4 
 
 5 
Figure S1. Colocalization of virus particles with the carbohydrate-rich extracellular matrix, Related to 6 
Figure 1. PBMC were infected with EHV-1RFP (red; MOI=0.5) for 1 hr (a) and 24 hr (b and c). Cell surface 7 
glycoproteins of the ECM were stained green with FITC-labeled ConA. PBMC nucleus was stained with 8 
DAPI (blue). After 24 hr, EHVRFP viral particles were detected outside the cells colocalizing with ECM (b) 9 
as well as inside the PBMC (c, arrowheads). Data are representatives of three independent experiments. 10 
Scale bar = 10 μm and scale bar of magnification = 7 μm. Image stacks (number of stacks = 17 with 11 
0.75 μm z-stack step size) were photographed using VisiScope Confocal FRAP microscope. Presented 12 
here is a single optical section of the stacks. (d) 3D overview of embedded viruses in the ECM. Red: 13 
RFP-labeled virus particles; green: FITC-labeled ConA. (D1 and D2) are the front overviews, (D3 and D4) 14 
are the side overviews and (D5 and D6) are the back overviews. The 3D images were reconstituted from 15 
total projection of stack series image planes (number of stacks = 17) with 0.75 μm z-stack step size. 16 
 
 17 
Figure S2. Colocalization of virus particles with the carbohydrate-rich extracellular matrix after 7 18 
days of infection, Related to Figure 1. PBMC were infected with EHV-1RFP (red; MOI=0.5) for 24 hr and 19 
up to 7 days. At different time points (day 1, 2, 3, 5 and 7) PBMC surface glycoproteins of the ECM were 20 
stained green with FITC-labelled ConA. Nucleus was stained with DAPI (blue). Data are representatives 21 
of three independent experiments. Scale bar = 30 µm and scale bar of the magnification = 5 µm. Image 22 
stacks (number of stacks = 15 with 0.5 μm z-stack step size) were photographed using VisiScope 23 
Confocal FRAP microscope. Presented here is a single optical section of the stacks. 24 
 
 25 
Figure S3. Colocalization of virus particles with the carbohydrate-rich extracellular matrix, Related 26 
to Figure 1. PBMC were infected with EHV-1RFP (MOI=0.5) for 5 min. Cell surface glycoproteins of the 27 
ECM were stained green with FITC-labelled ConA. Plasma membrane was stained with CellVue® Claret 28 
Far Red Fluorescent dye (red) and nucleus was stained with DAPI (blue). Two independent 29 
representative experiments are shown (a-d and e-f). EHV-1RFP viral particles (yellow) were detected 30 
outside cells colocalizing with ECM (c and g), but not with plasma membrane (b and f). Scale bar = 30 31 
µm and scale bar of the magnification = 5 µm. Image stacks (number of stacks = 15 with 0.5 μm z-stack 32 
step size) were photographed using VisiScope Confocal FRAP microscope. Presented here is a single 33 




Figure S4. Extracellular matrix components of non-infected PBMC, Related to Figure 1. Cell surface 37 
glycoproteins of the non-infected PBMC stained green with FITC-labeled ConA (a), lectin from Triticum 38 
vulgaris (WGA; b), anti-collagen (c), anti-agrin (d), or anti-ezrin (e). PBMC nucleus was stained with DAPI 39 
(blue). Data are representatives of three independent experiments. Scale bar = 10 μm and scale bar of 40 
magnification = 7 μm. Image stacks (number of stacks = 17 with 0.75 μm z-stack step size) were 41 
photographed using VisiScope Confocal FRAP microscope. Presented here is a single optical section of 42 
the stacks. 43 
  44 
 
 45 
Figure S5.  Modulation of ECM on the surface of infected and non-infected PBMC, Related to 46 
Figure 1. PBMC were either mock-infected or infected with EHV-1RFP (MOI=0.5) for 5 min, 1 hr, or 24 hr. 47 
The cells were stained green with FITC-labeled ConA (a) or lectin from Triticum vulgaris (WGA; b). The 48 
experiment was performed three independent times in blinded fashion. The y-axis indicates the total 49 
number of cells involved in the assay. Kruskal–Wallis with Dunns test was used to compare modulation of 50 
ECM on infected cells at different time points to the non-infected cells; no significant difference was 51 
detected. (c) Confocal images showing non-homogenous (A and B) and homogenous (C and D) 52 
distribution of ECM stained with ConA (green). Nucleus was stained with DAPI (blue). Image stacks 53 
(number of stacks = 17 with 0.75 μm z-stack step size) were photographed using VisiScope Confocal 54 
FRAP microscope. Presented here is a single optical section of the stacks. 55 
 
 56 
Figure S6.  Virus transmission from infected PBMC to EC, Related to Figure 2. Number of counted 57 
viral particles embedded in the ECM of PBMC and transferred to EC is shown. PBMC were infected with 58 
EHV-1RFP (MOI=0.5) for 5 min and added to endothelial cells for 2 hr followed by fixation with PFA 4% 59 
and image stacks (number of stacks = 17 with 0.75 μm z-stack step size) were photographed using 60 
VisiScope Confocal FRAP microscope.  (a) Number of counted viral particles on the surface of PBMC and 61 
EC. (b) Number of PBMC and EC on which virus particles were present. The experiment was conducted 62 
one time in triplicate. 63 
 64 




Figure S7. Live cell imaging of virus transmission from infected PBMC to endothelial cells, 68 
Related to Figure 2. Time-lapse live cell imaging confocal microscopy showing EHV-1RFP+GFP viral 69 
particles transfer from the overlaid 5-min-infected-PBMC on endothelial cells. Viral particles (red, 70 
arrowhead) were visualized moving from infected PBMC to endothelial cells. Virus replication in EC is 71 
indicated by GFP expression, which is integrated in the viral genome (green) and production of new 72 
progenies RFP-labeled virus (red) in the infected cells. At time points 04:08 and 05:28 min, the green 73 
pseudocolor was removed to clearly expose virus-RFP signals. Image stacks (number of stacks = 15 with 74 
0.5 μm z-stack step size) were photographed using VisiScope Confocal FRAP microscope. Presented 75 
here is a single optical section of the stacks. 76 




Figure S8. EHV-1 transfer between PBMC, Related to Figure 2. PBMC infected with EHV-1RFP (red; 80 
MOI=0.5) for 1 hr and stained with ConA (green) display aggregates of two PBMC with the likelihood of 81 
virus transfer in between. Data are representatives of three independent experiments. Scale bar = 10 μm 82 
and scale bar of magnification = 7 μm. Image stacks (number of stacks = 17 with 0.75 μm z-stack step 83 
size) were photographed using VisiScope Confocal FRAP microscope. Presented here is a single optical 84 
section of the stacks. 85 




Figure S9. Virus particles on the surface of infected-PBMC, Related to Figure 3. Transmission 89 
electron microscopy (TEM) of EC grown on gridded coverslips and overlaid with EHV-1RFP infected-90 
PBMCs. Infected cells were observed either interacting with (a and b) or in close proximity (c and d) to 91 
EC. TEM images of the targeted PBMC show virus particles (white arrows) on the surface of infected 92 
PBMC. Marked parts with rectangles in (a and c) are magnified in (b and d, respectively). Scale bar = 1 93 
μm. 94 




Figure S10. Transcellular migration of infected-PBMC through endothelial cells, Related to Figure 98 
5. Ultrathin cross sections of PBMC crossing endothelial cells. PBMC were infected for 5 min with EHV-99 
1RFP and incubated over adherent EC for 3 hr. Partially digested infected-PBMC (at different stacks) is 100 
shown (a, d, g) and marked with a rectangle, which is magnified (b-c, e-f, h-i). Virus particles attached to 101 
migrating PBMC is marked with white arrows. Scale bar =1 μm. 102 
  103 
 
 104 
Figure S11. Expression of viral envelope glycoproteins (gD and gB) on the surface of infected 105 
PBMC, Related to Figure 6. PBMC were infected with EHV-1RFP (red; MOI=0.5) for 24 hr and probed 106 
with antibody against EHV-1 gD (a-c) or gB (d-f) followed by anti-mouse Alexa Fluor-488 (green). 107 
Nucleus was stained with DAPI (blue). Red signals on cell surface and within the cytoplasm or the 108 
nucleus of the infected PBMC indicates RFP-labelled virus particles and expression of viral capsid 109 
proteins. Data are representatives of three independent experiments. Scale bar = 30 µm and scale bar of 110 
the magnification = 5 µm. Image stacks (number of stacks = 15 with 0.5 μm z-stack step size) were 111 
photographed using VisiScope Confocal FRAP microscope. Presented here is a single optical section of 112 
the stacks. 113 
  114 
 
 115 
Figure S12. Colocalization of EHV-4 with the carbohydrate-rich extracellular matrix, Related to 116 
Figure 7. (a) PBMC were infected with EHV-4GFP (MOI=0.5) for 5 min. Cell surface glycoproteins of the 117 
ECM were stained with FITC-Labeled ConA (green). EHV-4 particles were stained with anti-glycoprotein 118 
D monoclonal antibodies (red). PBMC nucleus was stained with DAPI (blue). Data are representatives of 119 
three independent experiments. Scale bar = 10 μm and scale bar of magnification = 7 μm. Image stacks 120 
(number of stacks = 17 with 0.75 μm z-stack step size) were photographed using VisiScope Confocal 121 
FRAP microscope. Presented here is a single optical section of the stacks. (b and c) EHV-4 transmission 122 
from infected PBMC to EC under “static” and “dynamic” states. PBMC were infected with EHV-4GFP for 5 123 
min. Infected PBMC were added to EC under “static” conditions (b) or allowed to flow over EC “dynamic” 124 
(c) in the presence of neutralizing antibodies. After 24 hr, virus spread was assessed by counting the 125 
plaques on EC. As a control, infected PBMC were placed into a transwell insert without direct contact 126 
between EC and PBMC “no contact”. The data represent the mean ± standard deviation of three 127 
independent and blinded experiments. (d) PBMC were infected with EHV-4GFP (MOI=0.1) for 5 min. The 128 
ECM was disrupted with both mechanical (extensive pipetting) and chemical (heparin treatment) together 129 
(EHV-4_5M_Cell_pip_hep). The disrupted cells (d.1) or the supernatant (EHV-4_5M_Sup_pip_hep; d.2) 130 
were added to EC.  As a control, the ECM was left undisrupted (EHV-4_5M_Cell or EHV-4_5M_Sup). As 131 
a control of pipetting and heparin treatment, EHV-1 was used. The data represent the mean ± standard 132 
deviation of three independent and blinded experiments with EHV-4. Cells were infected with EHV-1 once 133 
to confirm virus spread and infection (see Fig 4a and b). (e) Endothelial cells are permissive for EHV-4 134 
cell-free viruses.  EC were infected with EHV-4GFP (MOI 0.1) for 1 hr. Virus and media were removed and 135 
the cells were overlaid with methylcellulose media 1.5% for 3 days. EHV-4 GFP-expressing viral plaques 136 
were imaged with Carl Zeiss AXIO imager microscope equipped with a Zeiss Axiocam. Scale bar = 70 137 




Figure S13. Transcellular migration of PBMC through endothelial cells, Related to Figure 5. 141 
Ultrathin cross section of non-infected PBMC crossing endothelial cells. Partially digested naïve PBMC is 142 
shown within a cytoplasmic vacuole of EC. The migrating PBMC marked with a rectangle in (a, red arrow) 143 
is magnified in (b, red arrow). Scale bar = 1 μm.   144 
  145 
 
Transparent Methods 146 
Methods 147 
Viruses. All viruses used in this study were produced and recovered from infectious bacterial artificial 148 
chromosome (BAC) clones. Those were BACs of EHV-1 (EHV-1GFP) strain Ab4 (Goodman et al., 2007), 149 
EHV-4 (EHV-4GFP) strain TH20p(Azab et al., 2009), recombinant EHV-1_gB4 and EHV-4_gB 150 
(Spiesschaert et al., 2015b), and EHV-1_gD4 and EHV-4_gD1 (Azab and Osterrieder, 2012). Viruses 151 
were grown on equine dermal (ED) cells (CCLV-RIE 1222, Federal Research Institute for Animal health, 152 
Germany) (Spiesschaert et al., 2015b). All recombinant viruses express the enhanced green fluorescent 153 
protein (EGFP; encoded in the mini-F sequence under the control of the immediate-early CMV promotor) 154 
for efficient identification of infected cells. All virus stocks were prepared by infecting ED cells until having 155 
100 % cytopathic effect (CPE). Infected cultures (supernatant and cells) were collected and centrifuged at 156 
6000 x g for 5 min to get rid of cellular debris. Virus-rich supernatants were collected and stored at -80 °C.  157 
mRFP1-labeled viruses. Insertion of monomeric red fluorescent protein (mRFP1) into VP26 of EHV-1 158 
Ab4 strain  was performed as described before (Azab et al., 2013b; Tischer et al., 2006). Briefly, mRFP1 159 
was amplified by PCR using pEPmRFP1-in (Tischer et al., 2006) as a template; all used primers are 160 
referenced in (Azab et al., 2013b). The resulting PCR products were electroporated into GS1783 (a kind 161 
gift from Dr. Greg Smith, Northwestern University, Chicago, IL) harboring the corresponding BACs (EHV-162 
1 with and without GFP; to give rise of EHV-1RFP+ GFP and EHV-1RFP, respectively). Kanamycin-resistant 163 
colonies were purified and screened by PCR and restriction fragment length polymorphism (RFLP) 164 
analyses using EcoRV and BamHI. Positive clones were subjected to a second round of Red 165 
recombination to obtain the final constructs after excision of kanamycin gene. The final clones were 166 
confirmed by PCR, RFLP and sequencing (data not shown). All viruses (EHV-1RFP+ GFP and EHV-1RFP) 167 
were reconstituted as described before (Azab et al., 2013b).  168 
Cells. Primary equine carotid artery endothelial cells (a kind gift from Prof. Dr. Johanna Plendl, Freie 169 
Universität Berlin, Institut für Veterinär-Anatomie) were propagated in Dulbecco’s modified Eagle’s 170 
medium (DMEM) (PAN-Biotech Ltd, Germany) supplemented with 20% fetal bovine serum (FBS) (PAN-171 
Biotech Ltd, Germany), 1% nonessential amino acids (Biochrom, Germany), and 1% penicillin-172 
streptomycin. Endothelial cells were obtained according to the rules of Institutional Animal Care and 173 
Committee of Berlin (Landesamt für Gesundheit und Sociales, L 0089/14). Equine PBMC were isolated 174 
from heparinized blood collected from healthy horses by density gradient centrifugation over Biocoll L 175 
6715 (Biochrom, Germany), following the manufacturer’s instructions. After two washing steps, cells were 176 
resuspended in RPMI-1640 (Pan Biotech, Germany) supplemented with 10% FBS, 0.3 mg/ml glutamine, 177 
nonessential amino acids, and 1% penicillin-streptomycin. Blood collection was performed according to 178 
the rules of Institutional Animal Care and Committee of Berlin (Landesamt für Gesundheit und Sociales, L 179 
0294/13). PBMC were negative for both EHV-1 and EHV-4 as tested by qPCR (data not shown). PBMC 180 
were either used fresh after isolation or preserved in liquid-nitrogen and reconstituted when needed. 181 
Plasmids. For assessing fusion assay by luciferase activity measurement, we used pT7EMCLuc plasmid, 182 
which expresses firefly luciferase reporter gene under the control of T7 promoter, and pCAGT7 plasmid, 183 
which expresses T7 RNA polymerase. Both plasmids were kindly provided by Dr. Richard Longnecker, 184 
Northwestern University. A plasmid expressing mRFP under the control of Human CMV promoter, pEP-185 
CMVmRFP-in (Campbell et al., 2002; Tischer et al., 2006), was used for fusion assay. pEPmRFP1-in 186 
carrying kanamycin mRFP cassette had been used as a shuttle plasmid for EHV-1 strain Ab4-mRFP-187 
VP26 construction.  188 
Antibodies. FITC-labeled ConA (C7642), Triticum vulgaris (WGA; L4895) were from Sigma. Mouse anti-189 
agrin antibody (D-2: sc-374117) and mouse anti-ezrin antibody (3C12: sc-58758) were from Santa Cruz 190 
Biotechnology. Rabbit anti-human Collagen I/II/III/IV/V was from (Biorad: 2150-2206). Mouse anti-EHV-4 191 
gD Mab was kindly provided by Jules Minke, Merial: 105E2K (Azab et al., 2013a). Mouse Anti-EHV-1 gD 192 
19-mer polyclonal antibodies (Allen and Yeargan, 1987) were kindly provided by Dr. Dennis O’Callaghan, 193 
Louisiana State University Health Sciences Center, Shreveport, LA. Mouse EHV-1 anti-gB monoclonal 194 
antibodies (mAb) (Wellington et al., 1996) were kindly provided by Dr. Udeni B. R. Balasuriya, Gluck 195 
equine research center, University of Kentucky, KY. 196 
 
Confocal microscopy and immunofluorescence. For detection of the extracellular carbohydrate-rich 197 
matrix, 2x106 PBMC (in suspension) were infected with EHV-1RFP or EHV-4GFP (MOI=0.5) for 5 min, 1 hr, 198 
24 hr, 2 days, 3 days, 5 days, and/or 7 days.  Cells were centrifuged at 400 x g for 5 min and treated with 199 
ice cold citrate buffer (pH 3) for 1.5 min. The cells were washed three times with PBS and fixed with 4% 200 
Paraformaldehyde (PFA) for 20 min. For EHV-4, virus particles were stained with mouse anti-EHV-4 gD 201 
monoclonal antibody followed by Alexa Fluor 568-labeled goat anti-mouse IgG (1:1000; Invitrogen 202 
1841756). The carbohydrate-rich extracellular matrix was stained with FITC-labelled ConA and WGA 203 
(dilutions were 1:250 and 1:1000, respectively). Collagen, agrin and ezrin were stained by rabbit anti-204 
human Collagen I/II/III/IV/V, mouse anti-agrin antibody, and mouse anti-ezrin antibody with dilutions of 205 
1:100, 1:50, and 1:50, respectively, followed by Alexa Fluor 488-labeled goat anti-rabbit (1:1000; 206 
Invitrogen: 1966932) and anti-mouse IgG (1:1000; Invitrogen: 2015565). Plasma membrane was stained 207 
with CellVue® Claret Far Red Fluorescent dye (Sigma-Aldrich). DAPI (Life Technologies) was used to 208 
stain the nucleus. Image stacks (number of stacks = 15-17 with 0.5-0.75 μm z-stack step size) were 209 
photographed using VisiScope Confocal FRAP microscope (×40 magnification) and equipped with 210 
ANDOR iXon Ultra 888 camera (Visitron Systems GmbH, Germany). The images were processed and 211 
analyzed by using Image J software (https://imagej.nih.gov/ij/) and Metamorph software 7.8 (Molecular 212 
Devices). 213 
In another experiment, 1x106 PBMC were infected with EHV-1RFP (MOI=0.5). All infected cells were 214 
treated with ice-cold citrate buffer and virus-neutralizing antibodies as described above. The cells were 215 
added to endothelial cell monolayers for 2 hr. The cells were fixed and stained with FITC-labeled ConA 216 
and WGA. Image acquisition, processing and analysis were performed as mentioned above.  217 
Flow chamber assay. The assay was performed as previously described (Spiesschaert et al., 2015b). 218 
Briefly, PBMC (1x106) were infected with EHV-1GFP or EHV-4GFP (MOI=0.5) for different time points (5 219 
min, 1 hr, 6 hr). PBMC were treated with ice-cold citrate buffer (pH 3). The infected cells were washed two 220 
times and resuspended in medium containing 1:100 dilution of virus neutralizing antibody (titer: 1:2028 as 221 
determined by serum neutralization test (Azab et al., 2019)) at 37°C for 30 min (Goehring et al., 2011; 222 
Spiesschaert et al., 2015a). Endothelial cells were grown to confluency in 0.4 collagen IV-coated cell flow 223 
chambers (Ibidi Integrated BioDiagnostics) that were connected to a perfusion system by Luer locks (Ibidi 224 
Integrated BioDiagnostics). The flow chamber set was incubated at either 4°C or 37°C. Infected PBMC 225 
were introduced at a flow rate of 0.5 mm/s, which is within the mammalian physiological range (0.34 to 226 
3.15 mm/s) (Hudetz et al., 1996). The velocity was calculated according to the size of the chamber and 227 
the velocity in mammalian brain capillaries and was generated by a NE-4000 double-syringe pump (New 228 
Era Pump System). After 24 hr, GFP-viral plaques on the EC monolayer were counted (excluding the 229 
inlet/outlet areas) using an inverted fluorescence microscope and equipped with AxioCam MRc camera 230 
(Zeiss Axiovert 100).   231 
To evaluate virus transfer from different PBMC subpopulations (i.e. T lymphocyte, B lymphocyte and 232 
monocytes) to EC, each PBMC subpopulation was sorted out and flow chamber assay was performed. 233 
Briefly, PBMC were stained with (1:200 diluted) primary mouse antibodies against equine CD3 (T 234 
lymphocyte), IgM (B lymphocyte) and CD14 (monocyte). The antibodies were kindly provided by Dr. 235 
Bettina Wagner, Cornell University, Ithaca, NY, USA. PBMC were then labelled with secondary Alexa 236 
Fluor 488-conjugated goat anti-mouse IgG antibody (Invitrogen) and sorted using FACSAria (BD 237 
BioscienceTM). Sorted T- lymphocytes, B-lymphocytes and monocytes (1x106) were infected with EHV-238 
1GFP (MOI=0.5) for 5 min at 37 ºC. After incubation, cells were treated with citrate buffer, resuspended in 239 
EHV-1 neutralizing antibodies and flow chamber experiment was performed as described above.  240 
Contact assay. PBMC (5x105) were infected with EHV-1GFP or EHV-4GFP at MOI of 0.1 at different time 241 
points (5min, 1 hr, and 6 hr). Infected cells were treated with ice-cold citrate buffer and added to EC for 2 242 
hr in the presence of virus neutralizing antibody as described above. Non-adherent cells were then 243 
removed by extensive and gentle washing with PBS. In the “no-contact” setup, virus-infected PBMC were 244 
placed into a transwell insert (with a membrane pore size of 0.4 µm; Corning Transwell support system) 245 
without direct contact with EC. Methylcellulose 1.5% was added and cells were incubated for 24 hr. Virus 246 
transfer was assessed by counting the green fluorescent viral plaques using an inverted fluorescence 247 
microscope (Zeiss Axiovert 100). 248 
 
Disruption of extracellular virus assemblies. PBMC (5x105) were infected with EHV-1RFP+GFP or EHV-249 
4GFP at MOI of 0.1 for 5 min as described above. The cells were subjected to vigorous pipetting, treated 250 
with heparin, or both. Heparin (50µg/ml; Sigma-Aldrich) was added to the cells for 30 min. PBMC (cells or 251 
supernatant) were added to EC for 2 hr. After washing, methylcellulose 1.5% was added to the cells. Viral 252 
plaques on EC were counted after 24 hr using an inverted fluorescence microscope. For confocal 253 
microscopy, EHV-1-infected PBMC were stained with FITC-labeled ConA and then treated with 254 
heparinase III (10 U ml−1) for 1 hr or heparin (50µg/ml) for 30 min at 37°C in serum-free medium. Image 255 
stacks were photographed using VisiScope Confocal FRAP microscope. Image acquisition, processing 256 
and analysis were performed as mentioned above. 257 
Fusion assays. Luciferase assay. Day 1: PBMC were nucleofected with 2μg pCAGT7 plasmid using 258 
Amaxa® Cell Line Nucleofector® Kit V (Lonza) according to the manufacturer instructions. Day 2: PBMC 259 
were infected with EHV-1GFP at MOI of 1. Endothelial cells were nucleofected with 2μg pT7EMCLuc and 260 
seeded in collagen-coated 24 well plate. Day 3: Nucleofected-infected-PBMC were washed and overlaid 261 
on the nucleofected endothelial cells. Day 4: Activation of the reporter luciferase gene resulted from 262 
fusion of nucleofected infected PBMC to nucleofected endothelial cells was measured by Luciferase 263 
Assay System kit (E1500, Promega, USA) using TriStar LB 941 Multimodal plate reader (Berthold 264 
Technologies) for luminescence measurement according to the manufacturer’s instructions (Promega). 265 
Briefly, endothelial cells were washed to remove non-fused PBMC and lysed with the lysis buffer. The 266 
lysed cells were left on a shaker for 15 min and 20 μl of the cell lysates were used for the reading. As 267 
negative controls, only nucleofected PBMC or only infected PBMC were overlaid on the nucleofected 268 
endothelial. As a positive control, PBMC were nucleofected with both plasmids (pCAGT7 and 269 
pT7EMCLuc). 270 
In another assay, PBMC were nucleofected with 2 μg pEP-CMVmRFP-in as described above. After 24 hr, 271 
nucleofected PBMC were infected with EHV-1GFP at MOI of 1. After 24 hr, nucleofected-infected PBMC 272 
were added to endothelial cells for 3.5 hr. Endothelial cells were washed and fixed with 4% PFA and 273 
analyzed using VisiScope Confocal FRAP microscope (×40 magnification). Images were pseudocolored 274 
according to their respective emission wavelengths, overlaid and processed using Image J and 275 
Metamorph softwares.  276 
To determine the expression of fusogenic viral glycoproteins (gB and gD) on the surface of infected PBMC, 277 
cells were infected with EHV-1RFP (MOI=0.5) for 24 hr. Infected cells were fixed with 4% PFA for 20 min 278 
and stained with primary mouse antibody against EHV-1 gB and gD (dilution of 1:250) for 1 hr. Goat anti-279 
mouse Alexa Fluor-488 was used as secondary antibody and nucleus was stained with DAPI. Cells were 280 
imaged using VisiScope Confocal FRAP microscope as described above. 281 
Live cell imaging. PBMC were infected with EHV-1RFP+GFP (MOI=3) for 5 min then the cells were treated 282 
with ice-cold citrate buffer and virus neutralizing antibody. The infected cells were added to endothelial 283 
cells grown on 8-wells ibidi slide coated with collagen (Ibidi Integrated BioDiagnostics). Cells were imaged 284 
in non-phenol red DMEM cell culture media (Pan Biotech, Germany) supplemented with 20% FBS, 285 
1% penicillin and streptomycin, and 1% non-essential amino acid. The temperature on the microscope 286 
stage was held stable during time-lapse sessions using an electronic temperature-controlled airstream 287 
incubator. The field area was chosen displaying EHV-1RFP+GFP viral particles (red signals) on the surface 288 
of PBMC overlaying the EC. Images were captured in time-lapse every 8 min time series using a 289 
VisiScope Confocal FRAP microscope (×20 magnification). Images and movies were generated and 290 
analyzed using ImageJ and Metamorph softwares. Long time-lapse experiments were carried out using 291 
the autofocusing function integrated into the advanced time series macro set. 292 
Correlative fluorescent and electron microscopy. For TEM analysis, endothelial cells were grown on 293 
correlative microscopy gridded coverslips (LCMC34A, Plano GmbH, Germany). PBMC were infected with 294 
EHV-1RFP (MOI=5) for 5 min then the cells were treated with ice-cold citrate buffer and virus neutralizing 295 
antibody. The infected-PBMC were overlaid on EC and incubated at 37°C for 1 or 3 hr. Cells were fixed 296 
with 4% PFA for 30 min at room temperature. Cell nuclei were counter-stained with 2µg/ml Hoechst 297 
33342 (Thermo Fisher Scientific, Germany) in PBS for 10 min at room temperature and kept in PBS after 298 
staining. Cells covering the region of one grid square on the coverslip were imaged using a 299 
CellDiscoverer 7 microscope (Carl Zeiss, Germany) at 20x magnification. For TEM, cells were then fixed 300 
on the coverslips in 2.5% glutaraldehyde (Grade I, Sigma, Germany) freshly prepared in PBS from a 25% 301 
 
stock solution (overnight at 4°C). After washing 3 times in PBS, coverslips were incubated in 0.5 % (v/v) 302 
osmium tetroxide (Science Services GmbH, Germany) in PBS for 1 hr at room temperature, washed 4 303 
times for 20 min in distilled water, incubated for 30 min in 100 mM Hepes buffer containing 0.1 % (w/v) 304 
tannic acid (Science Services, Germany), washed 3 times for 10 min in distilled water and then again 305 
incubated in 2 % (w/v) uranyl acetate (Sigma-Aldrich, Merck, Germany) for 1.5 hr at room temperature. 306 
After washing once in distilled water, samples were then dehydrated through a series of increasing 307 
ethanol concentrations (5 min in 30 %, 10 min in 50 %, 15 min each in 70%, 90%, 96% and finally 3 times 308 
10 min in absolute ethanol, respectively). Samples were then incubated overnight at 4°C in 100 % 309 
SPURR resin (Low Viscosity Spurr Kit, Ted Pella, CA, USA). After exchanging fresh SPURR resin 2 times 310 
(2 hr at room temperature), coverslips were mounted between two pieces of Aclar Embedding Film 311 
(Science Services, Germany) for polymerization (24 hr at 60°C). For TEM imaging, areas (comprising 312 
approximately 3x3 squares from the grid pattern) exhibiting 2-4 PBMC carrying a virus load closely 313 
attached to EC were cut out, mounted on a preformed resin dummy and embedded again in SUPRR 314 
resin in order to cut target cells with an orientation perpendicular to coverslip support. After 315 
polymerization, sample blocks were carefully trimmed close to the selected cells using a EM Trim2 316 
specimen trimmer (Leica Microsystems, Germany) followed by cutting 70 nm sections using a UC7 ultra-317 
microtome (Leica Microsystems, Germany) equipped with a 3 mm diamond knife (Diatome, Biel, 318 
Switzerland). Sections were placed on 3.05 mm carbon-coated Formvar copper slot grids (Plano GmbH, 319 
Germany) and post-contrasted using 2% (w/v) uranyl acetate and Reynolds lead citrate. TEM images 320 
were taken at 1100x - 6500x nominal magnification using a Tecnai Spirit transmission electron 321 
microscope (FEI) operated at 120 kV and equipped with a 4k x 4k F416 CMOS camera (Tietz Video and 322 
Image Processing Systems GmbH; TVIPS). 323 
Statistical analyses. Statistics were performed using SPSS 23 and GraphPad Prism 7. Normally 324 
distributed data sets, determined by the Shapiro-Wilk test, were analyzed with one-way analysis of 325 
variance (ANOVA) followed by Dunnett's test for multiple comparisons. Data sets that were not normally 326 
distributed were analyzed with Kruskal-Wallis test followed by Dunns test for multiple comparison tests.  327 
*, P < 0.05, **, P < 0.01, ***, P < 0.001. 328 
  329 
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